ClinicalTrials.gg
Not yet recruitingNCT06878937Updated Jun 17, 2025

'Thriving With Bipolar Disorder': Co-design and Evaluation of a Peer-Led Education Program Focused on Quality of Life

An interventional study of Peer Delivered Psychoeducation Program in Bipolar Disorder (BD) and Quality of Life (QOL), sponsored by University of British Columbia. Not yet recruiting at 1 site in Canada. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-06-17.

Sponsored by University of British Columbia · Not applicable, Interventional, and Supportive care

How we know

From the registry’s dates

  • Primary completion was expected by Dec 2025, 11 months ago, but the record still lists the study as not yet recruiting.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
44
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 15 studies in Bipolar Disorder by University of British Columbia — 3 open to participants now, 3 under way, 1 of them phase 3. Bipolar Disorder · University of British Columbia.

Planned enrollment
7th of 13
44 · median 44
Started
2025
the only one that year
No phase
5 of 15
2 open now
Registered
14th of 15
by date

Among the 15 studies in Bipolar Disorder by University of British Columbia, this one is the 7th largest by planned enrollment of the 13 interventional ones that give a count, is the only one that started in 2025, is one of 5 with no phase, and was the 14th registered.

Bipolar Disorder

1,687 studies on the registry are indexed under Bipolar Disorder; 268 are open to participants now.

Browse Bipolar Disorder studies →

Open to participants now

3 of the 15 studies in Bipolar Disorder by University of British Columbia are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 3 open studies →

Where they have run

Who these studies take

Of the 207 Bipolar Disorder studies recruiting now, 60 (29%) set no upper age limit and 134 (65%) stop at 75 or younger; 38 take children under 18; 51 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 15 studies in Bipolar Disorder by University of British Columbia, or all of them as a file.
02

Study summary

Self-management strategies can be used by individuals with bipolar disorder (BD) to cope with symptoms and improve quality of life (QoL). Peer-facilitated education programs have the potential to diversify delivery of self-management information by capitalizing on the expertise of individuals who live well with BD. We have co-designed a novel, peer-facilitated, QoL-focused, group education program for people living with BD. This project will involve administration of the program and an evaluation of the feasibility, acceptability, and efficacy of this program for self-management of BD.

Read the detailed description

Background and Purpose:

Peer support (where individuals with shared lived experience of a mental health condition provide each other with informational, emotional, and social support) may be an acceptable way to disseminate information on self-management strategies, capitalizing on the expertise and knowledge of people who live well with BD.

Peer-facilitated group psychoeducation includes the benefits of evidence-based self-management information and tools, with the added advantage of providing role models for recovery and modelling of self-management skills. Unfortunately, there is a dearth of BD-specific peer-facilitated self-management psychoeducation programs, and corresponding evaluations of their efficacy.

To capitalize on the potential of peer support to enhance the delivery of BD self-management information, content from two, web-based, self-directed psychoeducational interventions was adapted to create a peer-facilitated psychoeducation program using a community-based participatory research (CBPR) framework. The resulting program contains eight, weekly, two-hour sessions. Each session focuses on a topic related to QoL in BD (including Mood, Sleep, Physical Health, Relationships, Money, Self-esteem, and Independence), and contains a combination of education, opportunities for peer-to-peer knowledge exchange, and activities that facilitate practice of self-management strategies. A facilitator and attendee manual have been created for use in this program.

Methods:

The project will be implemented across two phases:

In the first phase, which we have already completed, we have applied CBPR principles to develop a peer-facilitated, QoL-focused group psychoeducation program for individuals with BD. The resulting program, entitled 'Thriving with bipolar disorder' will be delivered in eight, weekly, two-hour sessions that will be co-facilitated by two peer facilitators with lived experience of BD.

In the second phase, we will conduct a pilot evaluation of the feasibility, acceptability, and preliminary efficacy of the program. The program will be delivered through Hope+Me, an Ontario-based charity that supports people living with mood and anxiety disorders through education, advocacy, training, and support services. Four peer facilitators will be recruited through Hope+Me and will attend a \~5.5 hour training session prior to commencing the program. We will aim to recruit 32-40 program participants (8-10 per group) given previous research summarizing the ideal group size.

The evaluation will be conducted as a single-arm, uncontrolled, pilot feasibility trial. An explanatory sequential mixed-methods design will be used. The following data will be collected:

  • Participants will provide baseline demographic and clinical information in a survey as part of their consent.
  • Participants will complete surveys for efficacy measures at baseline, immediately after completing the program and 1 month after completing the program.
  • Program feedback will be collected from participants immediately after completing the program through a Qualtrics survey.
  • Peer facilitators will complete a brief, post-session Qualtrics survey each week, recording attendance, fidelity, and session feedback.

At the end of the intervention period, a subset of consenting participants (\~n=12) and peer facilitators (\~n=4) will be invited to participate in a one-hour qualitative individual interview over Zoom.

Study Population:

Four peer facilitators will be recruited through Hope+Me. We hope to recruit \~fourty program participants. Inclusion and exclusion criteria are specified in the 'Eligibility' section.

03

Conditions studied

  • Bipolar Disorder (BD)
  • Quality of Life (QOL)

Browse trials for

Keywords

  • Psychoeducation
  • Peer-Support
  • Bipolar Disorder
  • Quality of Life
  • Self-Management
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Program facilitators

    • aged 18 or older
    • a self-reported diagnosis of a mood disorder
    • sufficient access to an internet-enabled computer or smartphone device to access the Zoom teleconferencing platform
    • ability to understand, read and write English
    • at least one year of prior experience leading peer support groups or recovery programs through Hope+Me
    • previously received training through Hope+Me
    • completed a Criminal Records Check
  2. Program participants

    • aged 18 or older
    • residing in Canada
    • a self-reported diagnosis of BD
    • ability to understand, read and write English
    • sufficient access to an internet-enabled computer or smartphone device to access the Zoom teleconferencing platform

Exclusion criteria

Exclusion Criteria:

  • inability to communicate in written and verbal English to a sufficient level to allow participation in the program and research activities
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
44 participants (estimated)

Study arms

  • Experimental
    Peer-Delivered Psychoeducation Program

    Individuals in this arm will complete the peer-delivered psychoeducation program.

    Behavioral: Peer Delivered Psychoeducation Program

Interventions

  • BehavioralPeer Delivered Psychoeducation Program

    The peer delivered psychoeducation program is the only intervention being tested in this pilot evaluation study.

06

What researchers measure

Primary outcomes

  1. Feasibility (Session Attendance)

    Feasibility will be assessed using program attendance rates. After each session, peer facilitators will complete a brief questionnaire to record the number of participants who attended each session. Feasibility is defined as the proportion of participants achieving the minimum attendance of 62.5% (i.e., five out of eight sessions), based on the median therapeutic dose in a review of group therapy program evaluations.

    Time frame: Every week, from enrollment to the end of the intervention at 8 weeks.

Secondary outcomes

  1. Patient Health Questionnaire 8 (PHQ-8)

    Self-reported depressive symptoms will be assessed by the Patient Health Questionnaire-8 (PHQ-8), which evaluates 8 of the 9 criteria for depression from the Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV). The eight Likert-type items ask about the frequency of depressive symptoms experienced in the past two weeks (0 = "Not at all" to 3 = "Nearly every day"). Responses are summed to create a total score (range: 0-24); higher scores indicate greater depression severity. The PHQ-8 performs comparably with clinician assessments; internal reliability has been demonstrated in population studies (Cronbach α=0.87). The PHQ-8 has comparable performance to the original nine item version (PHQ-9), which assesses all DSM-IV criteria, including current suicidal ideation. The PHQ-8 is chosen for this evaluation because this program doesn't incorporate formal psychiatric evaluation and supports, data collected is self-reported, and immediate follow-up isn't possible.

    Time frame: At enrollment, immediately after the intervention at 8 weeks, and a follow-up 4 weeks after the intervention.

  2. Quality of Life in Bipolar Disorder (QoL.BD) Scale

    The Quality of Life in Bipolar Disorder (QoL.BD) Scale will be used to assess aspects of QoL specifically impacted by or relevant to BD. This scale assesses 12 core aspects of QoL (mood, sleep, physical health, cognition, household management, leisure, finances, relationships, self-esteem, spirituality, identity, and independence). Each domain contains four Likert-type items that assess satisfaction with that area (1 = Strongly Disagree to 5 = Strongly Agree). An overall score can be calculated by summing responses to the 48 items (range: 48-240), with higher scores indicating greater life satisfaction. During psychometric testing, the factor structure of the QoL.BD has been supported, and the scale has demonstrated excellent internal reliability (Cronbach α\>0.8) and appropriate test-retest reliability. Construct validity has been supported through positive correlations with generic QoL instruments and negative correlations with depressive symptoms.

    Time frame: At enrollment, immediately after the intervention at 8 weeks, and a follow-up 4 weeks after the intervention.

  3. Altman Self-Rating Mania Scale

    Self-reported mania will be assessed using the Altman Self-Rating Mania Scale. This instrument measures behaviours and feelings during the past week using five items; a total score (range: 5-25) can be calculated by summing responses, with higher scores indicating more severe manic symptoms. Responses have been found to correlate strongly with clinician-rated mania; internal reliability is acceptable (Cronbach α\>0.65).

    Time frame: At enrollment, immediately after the intervention at 8 weeks, and a follow-up 4 weeks after the intervention.

  4. Bipolar Recovery Questionnaire

    Personal recovery will be measured using the Bipolar Recovery Questionnaire. Items are informed by qualitative interviews regarding experiences of personal (as opposed to clinical) recovery in BD. This scale contains 36 visual analogue scales (range: 0-100); responses are summed to create an overall score (range: 0-3600). Higher scores are indicative of better self-appraised recovery. This instrument has been found to be internally consistent (Cronbach α=0.875) and reliable over a month-long test-retest period.

    Time frame: At enrollment, immediately after the intervention at 8 weeks, and a follow-up 4 weeks after the intervention.

  5. Stanford's Chronic Disease Self-Efficacy 'Manage Disease in General' Subscale

    Self-efficacy will be measured using the 5-item Manage Disease in General subscale of Stanford's Chronic Disease Self-Efficacy Scale. The score on this subscale is the mean of 5 Likert-type items (1 = not at all confident to 10 = totally confident). Higher scores on this subscale (range: 1-10) indicate greater confidence in managing the symptoms and impacts of a chronic health condition.

    Time frame: At enrollment, immediately after the intervention at 8 weeks, and a follow-up 4 weeks after the intervention.

  6. Self-Compassion Scale-Short Form

    Self-compassion will be measured using the Self-Compassion Scale-Short Form (61, 62), which contains 12 Likert-type items (1=Almost Never, 5 = Almost Always) used to assess 6 dimensions of self-compassion: self-kindness, self-judgement, common humanity, isolation, mindfulness, and overidentification. Subscales are calculated by averaging relevant items. To calculate an overall score (range: 1-5), negative subscales are reverse-coded. Higher overall scores indicate more frequent self-compassionate behaviours and attitudes. Internal consistency has been demonstrated (Cronbach α=0.86); confirmatory factor analysis supports both the 6 subscales and a single higher-order factor of self-compassion.

    Time frame: At enrollment, immediately after the intervention at 8 weeks, and a follow-up 4 weeks after the intervention.

  7. Internalised Stigma of Mental Illness Scale Brief Version

    Self-stigma will be measured using the Internalised Stigma of Mental Illness Scale Brief Version. This instrument contains 9 Likert-type items (1= Strongly Disagree, 4 = Strongly Agree); two are reverse-coded. Item responses are averaged for an overall score (range: 1-4); higher scores indicate more internalized stigmatizing attitudes towards mental illness. Internal consistency has been demonstrated (Cronbach α=0.86); confirmatory factor analysis supports a unidimensional factor structure.

    Time frame: At enrollment, immediately after the intervention at 8 weeks, and a follow-up 4 weeks after the intervention.

  8. Social Provisions Scale Short Form

    Perceived social support will be measured using the Social Provisions Scale Short Form. This instrument contains 10 Likert-type items (1= Strongly Disagree, 4 = Strongly Agree) which evaluate an individual's perceptions of the availability of social support. An overall score (range: 10-40) and five subscales can be calculated by summing relevant items; subscales include guidance (receipt of information or advice), reliable alliance (practical help and support), reassurance of worth (feeling valued by others), attachment (emotional bonds), and social integration (sense of belonging to a group with shared interests and attitudes). Internal consistency of the scale has been supported (Cronbach α\>0.80).

    Time frame: At enrollment, immediately after the intervention at 8 weeks, and a follow-up 4 weeks after the intervention.

  9. Client Satisfaction Questionnaire-8

    The Client Satisfaction Questionnaire-8 will be used to assess attendees' satisfaction with the 'Thriving with Bipolar Disorder' program post-intervention. This instrument has high internal consistency (Cronbach α=0.91); higher scores have been associated with greater attendance of services and improved clinical outcomes

    Time frame: Immediately after the intervention at 8 weeks.

  10. Group Climate Questionnaire Short Form

    To describe the acceptability of the group climate, we will use the Group Climate Questionnaire short form. This is the most widely used measure of group therapy cohesion, and can be completed by a group member, facilitator, or observer; here, to minimize response burden on attendees, weekly feedback will be provided by facilitators. It contains 12 items describing specific behaviours that are rated on a 7-point Likert scale (where 0 indicates "not at all" and 7 indicates "extremely"), three subscales can be calculated based on the mean score of relevant items. These subscales are Engaged (which describes a positive working group atmosphere), Avoiding (which describes avoidance of responsibility for group dynamics), and Conflict (which describes tension and anger between group members).

    Time frame: Every week, from enrollment to the end of the intervention at 8 weeks.

  11. Feasibility (Fidelity)

    To evaluate fidelity, facilitators will self-report adherence to the manual using four self-report Likert-type items, asking them to report the degree to which they reviewed information as described in the manual, shared their own lived experiences, and facilitated group involvement in discussions and activities. This method of fidelity assessment was selected given that the use of external observers may impact participant willingness to participate in group discussions and activities. Similar self-reported fidelity assessments have previously been used in evaluations of peer-led programs.

    Time frame: Every week, from enrollment to the end of the intervention at 8 weeks.

Other outcomes

  1. Program and Facilitator Feedback

    We will query attendee perceptions of program content, delivery, the facilitator, and the group environment, using a series of Likert-scale statements developed by the research team (1 = "Strongly Disagree" to 5 = "Strongly Agree"). Open-ended items will allow attendees to provide free-text feedback on program strengths and areas for improvement.

    Time frame: Immediately after the intervention at 8 weeks.

  2. Qualitative Feedback

    Individual interviews (approximately one hour) will be conducted with a convenience sample of participants (\~n=12) and facilitators (\~n=4) post-intervention. A semi-structured interview guide will contain questions about the acceptability of program content and format, experiences of the group environment, perceptions of the facilitator, and changes experienced as a result of participation.

    Time frame: Immediately after the intervention at 8 weeks.

07

Study locations

1 site
08

References and documents

Publications

  • Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001 Sep;16(9):606-13. doi: 10.1046/j.1525-1497.2001.016009606.x. PubMed 11556941 ↗
  • Attkisson CC, Zwick R. The client satisfaction questionnaire. Psychometric properties and correlations with service utilization and psychotherapy outcome. Eval Program Plann. 1982;5(3):233-7. doi: 10.1016/0149-7189(82)90074-x. PubMed 10259963 ↗
  • Biggs K, Hind D, Gossage-Worrall R, Sprange K, White D, Wright J, Chatters R, Berry K, Papaioannou D, Bradburn M, Walters SJ, Cooper C. Challenges in the design, planning and implementation of trials evaluating group interventions. Trials. 2020 Jan 29;21(1):116. doi: 10.1186/s13063-019-3807-4. PubMed 31996259 ↗
  • Tse S, Yuen WWY, Murray G, Davidson L, Lai Q, Kan A. Combining technical and expert-by-experience knowledge in the quest for personal recovery from bipolar disorder: a qualitative study. BMC Psychiatry. 2019 Nov 26;19(1):368. doi: 10.1186/s12888-019-2357-3. PubMed 31771532 ↗
  • Proudfoot J, Parker G, Manicavasagar V, Hadzi-Pavlovic D, Whitton A, Nicholas J, Smith M, Burckhardt R. Effects of adjunctive peer support on perceptions of illness control and understanding in an online psychoeducation program for bipolar disorder: a randomised controlled trial. J Affect Disord. 2012 Dec 15;142(1-3):98-105. doi: 10.1016/j.jad.2012.04.007. Epub 2012 Aug 2. PubMed 22858215 ↗
  • Shin C, Lee SH, Han KM, Yoon HK, Han C. Comparison of the Usefulness of the PHQ-8 and PHQ-9 for Screening for Major Depressive Disorder: Analysis of Psychiatric Outpatient Data. Psychiatry Investig. 2019 Apr;16(4):300-305. doi: 10.30773/pi.2019.02.01. Epub 2019 Apr 24. PubMed 31042692 ↗
  • Wu Y, Levis B, Riehm KE, Saadat N, Levis AW, Azar M, Rice DB, Boruff J, Cuijpers P, Gilbody S, Ioannidis JPA, Kloda LA, McMillan D, Patten SB, Shrier I, Ziegelstein RC, Akena DH, Arroll B, Ayalon L, Baradaran HR, Baron M, Bombardier CH, Butterworth P, Carter G, Chagas MH, Chan JCN, Cholera R, Conwell Y, de Man-van Ginkel JM, Fann JR, Fischer FH, Fung D, Gelaye B, Goodyear-Smith F, Greeno CG, Hall BJ, Harrison PA, Harter M, Hegerl U, Hides L, Hobfoll SE, Hudson M, Hyphantis T, Inagaki M, Jette N, Khamseh ME, Kiely KM, Kwan Y, Lamers F, Liu SI, Lotrakul M, Loureiro SR, Lowe B, McGuire A, Mohd-Sidik S, Munhoz TN, Muramatsu K, Osorio FL, Patel V, Pence BW, Persoons P, Picardi A, Reuter K, Rooney AG, Santos IS, Shaaban J, Sidebottom A, Simning A, Stafford L, Sung S, Tan PLL, Turner A, van Weert HC, White J, Whooley MA, Winkley K, Yamada M, Benedetti A, Thombs BD. Equivalency of the diagnostic accuracy of the PHQ-8 and PHQ-9: a systematic review and individual participant data meta-analysis. Psychol Med. 2020 Jun;50(8):1368-1380. doi: 10.1017/S0033291719001314. Epub 2019 Jul 12. PubMed 31298180 ↗
  • Kroenke K, Strine TW, Spitzer RL, Williams JB, Berry JT, Mokdad AH. The PHQ-8 as a measure of current depression in the general population. J Affect Disord. 2009 Apr;114(1-3):163-73. doi: 10.1016/j.jad.2008.06.026. Epub 2008 Aug 27. PubMed 18752852 ↗
  • Morton E, Murray G, Yatham LN, Lam RW, Michalak EE. The Quality of Life in Bipolar Disorder (QoL.BD) questionnaire a decade on - A systematic review of the measurement of condition-specific aspects of quality of life in bipolar-disorder. J Affect Disord. 2021 Jan 1;278:33-45. doi: 10.1016/j.jad.2020.09.017. Epub 2020 Sep 7. PubMed 32949871 ↗
  • Morton E, Hou SH, Fogarty O, Murray G, Barnes S, Depp C; CREST.BD; Michalak E. A Web-Based Adaptation of the Quality of Life in Bipolar Disorder Questionnaire: Psychometric Evaluation Study. JMIR Ment Health. 2020 Apr 27;7(4):e17497. doi: 10.2196/17497. PubMed 32338620 ↗
  • Michalak EE, Murray G; Collaborative RESearch Team to Study Psychosocial Issues in Bipolar Disorder (CREST.BD). Development of the QoL.BD: a disorder-specific scale to assess quality of life in bipolar disorder. Bipolar Disord. 2010 Nov;12(7):727-40. doi: 10.1111/j.1399-5618.2010.00865.x. PubMed 21040290 ↗
  • MacKenzie, K. (1983). The clinical application of a group climate measure. In R.R. Dies & K.R. MacKenzie (Eds.), Advances in group psychotherapy: Integrating research and practice (pp. 159-170). International Universities Press.
  • Larsen DL, Attkisson CC, Hargreaves WA, Nguyen TD. Assessment of client/patient satisfaction: development of a general scale. Eval Program Plann. 1979;2(3):197-207. doi: 10.1016/0149-7189(79)90094-6. No abstract available. PubMed 10245370 ↗

Individual participant data

Plan to share: Yes — Individual participant data that underlie the results reported in any published articles after deidentification. Qualitative data will not be shared to protect privacy and confidentiality due to the potential risk of participant re-identification.

Supporting information: Study protocol, Statistical analysis plan

Time frame: Beginning 3 months and ending 3 years after article publication.

Access criteria: Researchers interested in using the data must provide a methodologically sound proposal. All requests should be directed to emma.morton@monash.edu. If a request is approved, the requesting party will need to secure behavioural research ethics board approval from their institution and sign a Clinical Study Data Transfer Agreement. Data will be shared using a secure file transfer service approved by the university (Microsoft OneDrive). The research team reserves the right to deny incomplete/inaccurate proposals, if there is a perceived conflict of interest, or if researchers cannot ensure sufficient measures are in place to maintain the security and privacy of the data.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Jun 2025; primary completion for Dec 2025, 6 months later.

Of 361 non-industry interventional studies with no phase under Bipolar Disorder, half reached primary completion within 37 months of starting (the median), counting those still running; a quarter within 23 and three quarters within 58. This study's planned 6 months is below that.

Counting every sponsor, half of 363 studies reached it within 37 months; a quarter within 23 and three quarters within 58.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 4, 2025
First posted
Mar 17, 2025
StartEst.
Jun 2025
Primary completionEst.
Dec 2025
CompletionEst.
Dec 2025
Last update
Jun 17, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 17, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06878937
Collaborators
Mood Disorders Association of Ontario
Responsible party
Erin Michalak (Professor, Department of Psychiatry, Faculty of Medicine, University of British Columbia) — Principal investigator
First posted
Mar 17, 2025
Start date
Jun 2025 (estimated)
Primary completion
Dec 2025 (estimated)
Completion
Dec 2025 (estimated)
Last update
Jun 17, 2025

Study contacts

Erin Michalak
Contact
erin.michalak@ubc.ca
604-827-3393
Emma Morton
Contact
emma.morton@monash.edu

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jun 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion